Mediphase Venture Partners
23
26M
8
3
0.65
7
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Newton. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Mediphase Venture Partners, startups are often financed by Skyline Ventures, New Leaf Venture Partners, Sprout Group. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, Sprout Group, Skyline Ventures. In the next rounds fund is usually obtained by OrbiMed, New Leaf Venture Partners, 5AM Ventures.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Relypsa, Serenex, PatientKeeper. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Besides them, we counted 2 critical employees of this fund in our database.
The top amount of exits for fund were in 2014. The top activity for fund was in 2007. Opposing the other organizations, this Mediphase Venture Partners works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 3
- Exits
- 7
- Follow on index
- 0.65
- Investments by industry
- Health Care (21)
- Biotechnology (18)
- Medical (11)
- Biopharma (9)
- Pharmaceutical (4) Show 4 more
- Investments by region
-
- United States (23)
- Peak activity year
- 2010
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 187M
- Group Appearance index
- 0.96
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.46
- Strategy success index
- 0.33
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Concert Pharmaceuticals | 30 Apr 2008 | Biotechnology, Health Care, Medical | Late Stage Venture | 37M | United States, Massachusetts |
| Wellpartner | 27 Mar 2007 | Health Care, Medical, Pharmaceutical | Late Stage Venture | 7M | United States, Oregon, Portland |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.